News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
Manufacturer's illustration of how Keytruda stops cancer cells hiding from the immune system.

Merck Provides Update on Phase 3 KEYNOTE-062 Trial Evaluating KEYTRUDA

Merck finds Keytruda no better than chemo as a first-line treatment for gastric cancer, according to a Phase 3 study. Results of which will be presented at the 55th annual ASCO meeting on June 2nd.

Read Source